Sponsored by:

Molecular Imaging: Page 441

MR-IMPACT trial: CMR equivalent to SPECT for stenosis detection
By Eric Barnes
In a prospective, randomized trial conducted at 18 sites internationally, MR first-pass myocardial perfusion imaging (perfusion-CMR) was at least equivalent to SPECT for detecting coronary artery stenosis, according to a new report in the European Heart Journal.
February 17, 2008
Carestream debuts new dye conjugates
By AuntMinnie.com staff writers
Carestream Molecular Imaging of New Haven, CT, has released its new Kodak X-Sight large stokes shift dye conjugates for fluorescent in vitro and in vivo imaging applications.
February 14, 2008
Siemens responds to FDA warning letter
By AuntMinnie.com staff writers
Siemens Medical Solutions' molecular imaging division has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the company's molecular imaging equipment, specifically the company's ECAT PET scanner.
February 14, 2008
Study reinforces V/Q, PIOPED II guidelines for PE during pregnancy
By Cynthia E. Keen
The results of an analysis of ventilation/perfusion (V/Q) scans performed over a seven-year period reinforce the recommendations of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II trial. The V/Q scan remains an excellent study to make or rule out the diagnosis of pulmonary embolism in pregnant women, according to researchers from Rhode Island.
February 14, 2008
Siemens forms Colorado R&D deal
By AuntMinnie.com staff writers
Siemens Medical Solutions and the National Jewish Medical and Research Center in Denver have formed a strategic alliance to improve and develop imaging and diagnostic technologies aimed at advancing personalized medicine.
February 12, 2008
Dilon taps Moussa as CEO
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has appointed Robert Moussa as president and CEO.
February 11, 2008
GE inks New York pact
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K., has signed a $4.4 million contract to supply IT products and a PET/CT scanner to ProHealth Care Associates.
February 10, 2008
Chalk River shutdown hurts Draxis' results
By AuntMinnie.com staff writers
Lower product sales in its radiopharmaceutical business combined with the stronger Canadian dollar to depress revenues at Canadian radiopharmaceutical developer Draxis Health of Montreal in 2007.
February 7, 2008
NRC investigates Covidien production issue
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) said it is working with Mallinckrodt, a division of Covidien of Hamilton, Bermuda, to investigate elevated levels of molybdenum-99 in the company's technetium-99m isotope.
February 7, 2008
Medical sales drive Covidien's Q1 growth
By AuntMinnie.com staff writers
Double-digit sales growth in its medical devices and imaging divisions helped contribute to increased first-quarter revenue for Covidien of Hamilton, Bermuda.
February 6, 2008
Digirad revenues edge up, loss narrows
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad of Poway, CA, turned in stronger financial results based on higher annual revenues and decreased operating expenses for 2007.
February 6, 2008
NuView, Thomas Jefferson to collaborate
By AuntMinnie.com staff writers
NuView Radiopharmaceuticals of Park City, UT, has entered an agreement with Thomas Jefferson University to distribute and commercialize a tumor-specific imaging agent used in the diagnosis of breast and prostate tumors.
February 5, 2008
Previous Page
Page 441 of 612
Next Page